As the world grappled with lockdowns and restrictions brought by the COVID-19 pandemic, researchers at Osaka Metropolitan University conducted an extensive study to elucidate the link between changes in human mobility and the impact on medical costs associated with lifestyle-related diseases.
First-in-Class Drug Approved for Heavily Pretreated Myeloma
The FDA granted accelerated approval to talquetamab (Talvey) for treating adults with relapsed or refractory multiple myeloma who have received at least four prior lines
August 11, 2023